Endothelial function for the evaluation of anti-atherosclerotic drugs.
Okumura
Kenji
K
Department of Cardiovascular Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan. kenji@med.nagoya-u.ac.jp
Cheng
Xian Wu
XW
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology*; D012307:Risk Factors
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000893:Anti-Inflammatory Agents